# Mitomycin C

## Mitonco inj 10mg

| TAH Drug Code      | [IMIT3](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IMIT3)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Relief of gastric cancer, bladder cancer (Intravesical therapy), lung cancer, sarcoma, leukemia, and other symptoms.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | Bladder cancer (Intravesical therapy) for prevention of relapse: once a day or every other day, inject Mitomycin C 4-10mg into the bladder. For treatment: once a day, inject Mitomycin-C 10-40 mg into the bladder. The dosage could be increased or decreased according to age and symptoms.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Contraindications  | History of hypersensitivity or idiosyncratic reaction to mitomycin.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Adverse Effects    | Common Gastrointestinal: Abdominal pain (Pyelocalyceal instillation, 28% ), Inflammatory disease of mucous membrane (20% to 40% ), Loss of appetite, Nausea (Pyelocalyceal instillation, 25% ), Nausea and vomiting (100% ), Vomiting (Pyelocalyceal instillation, 20% ) Ophthalmic: Blebitis, Cataract, Disorder of cornea, Endophthalmitis, Hyphema, Hypotony of eye, Leaking filtering bleb, Retinal hemorrhage, Thrombosis of retinal vein Renal: Dysuria (Pyelocalyceal instillation, 23% ), Flank pain (Pyelocalyceal instillation, 41% ), Hematuria (Pyelocalyceal instillation, 34% ), Renal impairment (Pyelocalyceal instillation, 25% ), Urinary tract infectious disease (Pyelocalyceal instillation, 34% ) Other: Fatigue (Pyelocalyceal instillation, 27% ), Fever (Pyelocalyceal instillation, 13% ) Serious Dermatologic: Cellulitis Hematologic: Disseminated intravascular coagulation, Myelosuppression (64.4% ), Neutropenia, Grade 3 (1.4% ), Thrombocytopenia, Grade 3 (4.2% ) Renal: Hemolytic uremic syndrome, Occlusion of ureter (Pyelocalyceal instillation, 58% ) |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest High Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Lactation          | Hold Breast Feeding                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| More Info          | [UpToDate](https://www.uptodate.com/contents/mitomycin-intravenous-and-intravesical-systemic-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

